A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity

Figure 3

The survival curve of SLC12A5 in various tumors using the Kaplan-Meier methods. The survival curves of SLC12A5 for overall survival (OS) in (a) KIRC, (b) LAML, (c) UCEC, (d) PRAD, and (e) PAAD. The survival curve of SLC12A5 for disease-specific survival (DSS) in (f) ESCA, (g) KIRC, (h) PRAD, and (i) KIRP.